DIFFERENTIAL EXPRESSION OF METALLOPROTEINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE GENES IN AGED HUMAN FIBROBLASTS

被引:196
|
作者
MILLIS, AJT
HOYLE, M
MCCUE, HM
MARTINI, H
机构
[1] Center for Cellular Differentiation, Department of Biological Sciences, University at Albany, Albany, NY 12222
关键词
D O I
10.1016/0014-4827(92)90286-H
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The basal levels of mRNAs encoding two metalloproteinases, collagenase and stromelysin, were increased as a function of in vitro serial subcultivation (cellular aging) of human fibroblasts. Procollagenase and prostromelysin synthesis and secretion were also greater in the old cultures (late passage). In contrast, the steadystate expression of mRNA for an inhibitor of metalloproteinases, tissue inhibitor of metalloproteinase-1 (TIMP-1), in late-passage cultures was lower than that in young cell cultures (early passage). Each mRNA was analyzed using total RNA preparations isolated from normal fibroblast cultures at different phases of the in vitro life span and from cultures derived from donors with the premature senescence syndromes characterized as Werner syndrome, progeria (Hutchinson-Gilford) syndrome, or Cockayne syndrome. In normal cell cultures expression of metalloproteinase mRNAs was increased after the culture had completed >90% of the in vitro life span, and the reduction in TIMP-1 mRNA expression occurred after the culture had completed >74% of the in vitro lifespan. In Werner syndrome cultures expression of metalloproteinase and TIMP-1 mRNAs was similar to the level of expression observed in late-passage cell cultures. Levels of metalloproteinase and TIMP-1 mRNA expression in progeria and Cockayne syndromes were similar to those of early-passage cell cultures. To determine if young and old cells were each responsive to mediators of metalloproteinase synthesis, cultures were treated with phorbol ester or cytokines. 12-O-tetradecanoylphorbol-13-acetate treatment increased the steady-state levels of all three mRNAs in young, old, and Werner syndrome cultures and increased procollagenase levels in all cultures. Early- and late-passage cell cultures also responded to cytokines. Interleukin-1α treatment increased collagenase and stromelysin mRNA levels while transforming growth factor-β reduced the steady-state levels of both transcripts. Neither cytokine affected the steady-state level of TIMP-1 mRNA. The results indicate that in vitro cellular aging is associated with changes in expression of mRNAs encoding proteins that mediate inflammatory responses and connective tissue remodeling. © 1992.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 50 条
  • [31] DIFFERENTIAL EXPRESSION OF MATRIX-METALLOPROTEINASE-1 AND MATRIX-METALLOPROTEINASE-2 GENES IN NORMAL AND FIBROTIC HUMAN LIVER
    MILANI, S
    HERBST, H
    SCHUPPAN, D
    GRAPPONE, SC
    PELLEGRINI, G
    PINZANI, M
    CASINI, A
    CALABRO, A
    CIANCIO, G
    STEFANINI, F
    BURROUGHS, AK
    SURRENTI, C
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1994, 144 (03): : 528 - 537
  • [32] Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A
    Song, XZ
    Xia, JP
    Bi, ZG
    [J]. CHINESE MEDICAL JOURNAL, 2004, 117 (12) : 1838 - 1841
  • [33] Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A
    宋秀祖
    夏济平
    毕志刚
    [J]. Chinese Medical Journal, 2004, (12)
  • [34] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [35] Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A
    宋秀祖
    夏济平
    毕志刚
    [J]. 中华医学杂志(英文版), 2004, (12) : 79 - 82
  • [36] Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis
    Wang, Ying-De
    Yan, Pei-Yun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (37) : 6050 - 6053
  • [37] Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer
    Ross, JS
    Kaur, P
    Sheehan, CE
    Fisher, HAG
    Kaufman, RA
    Kallakury, BVS
    [J]. MODERN PATHOLOGY, 2003, 16 (03) : 198 - 205
  • [39] Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation
    Gramley, Felix
    Lorenzen, Johann
    Plisiene, Jurgita
    Rakauskas, Mindaugas
    Benetis, Rimantas
    Schmid, Michael
    Autschbach, Ruediger
    Knackstedt, Christian
    Schimpf, Thomas
    Mischke, Karl
    Gressner, Axel
    Hanrath, Peter
    Kelm, Malte
    Schauerte, Patrick
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (10) : 1076 - 1082
  • [40] CDNA CLONING AND EXPRESSION OF A METALLOPROTEINASE INHIBITOR RELATED TO TISSUE INHIBITOR OF METALLOPROTEINASES
    BOONE, TC
    JOHNSON, MJ
    DECLERCK, YA
    LANGLEY, KE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) : 2800 - 2804